Navigation Links
Wyeth Announces Holder Right to Surrender Convertible Debentures
Date:6/16/2009

MADISON, N.J., June 16 /PRNewswire-FirstCall/ -- Wyeth (NYSE: WYE) (the "Company") announced today that holders of Wyeth Floating Rate Convertible Senior Debentures due 2024 (the "Convertible Debentures") have the right to surrender their Convertible Debentures for purchase by Wyeth pursuant to their terms effective on the July 15, 2009 purchase date. As of June 12, 2009, there was $787,803,000 in aggregate principal amount of Convertible Debentures outstanding.

At the option of each holder, Convertible Debentures will be purchased by the Company at a cash purchase price of $1,000 per $1,000 principal amount at maturity of the Convertible Debentures, plus accrued and unpaid interest to, but excluding, the purchase date, if any.

Because the purchase date coincides with the July 15, 2009 interest payment date, there should be no accrued but unpaid interest payable on the Convertible Debentures on the purchase date, although regular interest payments will be due on the same date to all holders of record on July 1, 2009, the regular interest payment record date.

Holders who were not the record holders of Convertible Debentures on July 1, 2009 will not be entitled to receive the July 15, 2009 interest payment on the Convertible Debentures.

The current conversion rate of the Convertible Debentures is 16.7356 shares of Wyeth common stock, par value $0.33 1/3 per share (the "Common Stock"), payable at the option of the Company in cash and/or Common Stock, if any, per $1,000 aggregate principal amount at maturity of Convertible Debentures outstanding, which is equivalent to a current conversion price of approximately $59.7529 per share.

Assuming that the price per share of the Common Stock is $44.80, the closing price of the Common Stock on the New York Stock Exchange on June 12, 2009,
'/>"/>

SOURCE Wyeth
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Wyeth Declares Common Stock Dividend
2. New Phase 3 Data Continue to Indicate that Wyeths Investigational 13-valent Vaccine Has the Potential to Broaden Coverage Against Pneumococcal Disease
3. Wyeth Sets Webcast and Conference Call For 2009 Second Quarter Earnings
4. Wyeth Announces Full Redemption of $2 Convertible Preferred Stock
5. Wyeth Declares Common and Preferred Stock Dividends
6. Wyeth Sets Webcast and Conference Call for 2009 First Quarter Earnings
7. Wyeth to Present at the SG Cowen & Co. 29th Annual Healthcare Conference
8. Wyeth to Present at the Goldman Sachs Healthcare CEOs Unscripted Conference
9. Wyeth Names Michael Kamarck President, Technical Operations & Product Supply
10. Wyeth Declares Preferred Stock Dividend
11. Wyeth Reports Earnings Results for the 2008 Third Quarter and First Nine Months
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/10/2009)... 10 Vivakor, Inc. (OTC Bulletin ... entered into an exclusive, $5 million license ... Inc. ( www.regeneca.com ). The agreement ... a new cutting-edge nutraceutical formulation developed by ... future formulations by Vivakor for Regeneca. Under ...
(Date:12/10/2009)... 10 Biomatrica, the leader in room ... of SampleWare 3.1 software system for laboratory inventory, ... release now includes an audit trail functionality that ... more complete history of any stored sample. ... offers customers a much needed ability to track ...
(Date:12/10/2009)... 10 Dendreon Corporation (Nasdaq: DNDN ) ... as chief operating officer, effective January 4, 2010. ... specialty medicine business at Bayer, where he was responsible ... products. Mr. Bishop also served as an executive ... a member of the Dendreon executive management team, Mr. ...
(Date:12/10/2009)... Dec. 10 Northwest Biotherapeutics, Inc. ("NWBT" or ... Robert A. Farmer has joined the company,s Board of ... and Harvard Law School, currently serves on six other ... the national treasurer of four presidential campaigns, including those ... Glenn. In those roles, he led fundraising of ...
Breaking Biology Technology:Vivakor Receives $5 Million Licensing and Purchase Agreement for Nutraceutical Products 2Vivakor Receives $5 Million Licensing and Purchase Agreement for Nutraceutical Products 3Biomatrica Launches SampleWare 3.1 2Biomatrica Launches SampleWare 3.1 3Dendreon Appoints Hans Bishop as Chief Operating Officer 2Northwest Biotherapeutics Announces Appointment of Robert A. Farmer to the Board of Directors 2Northwest Biotherapeutics Announces Appointment of Robert A. Farmer to the Board of Directors 3
... The nation's space agency announced this month it wants to return ... for the longer trip to Mars . Others say the ... Earth's lifeless satellite and head directly for the red planet, ... government should get out of the business of space flight and ...
... - Sonic Foundry, Inc. , has announced it ... shares of common stock at $3.75 per share. ... close on Dec. 27, 2006, will be used to ... the company's search technology and intellectual property protection. The ...
... national and international pipeline to Wisconsin might have been put ... a Norwegian biotechnology and stem cell research company, will be ... , ,CellCura, the fourth stem cell company to start or ... following an international search and will open in Madison with ...
Other Biology Technology:Flying to the moon? Take Wisconsin tech along 2Flying to the moon? Take Wisconsin tech along 3Flying to the moon? Take Wisconsin tech along 4CellCura could start an invasion of stem cell firms 2CellCura could start an invasion of stem cell firms 3
(Date:12/13/2009)... led by Yale University researchers has used nanosensors ... the first time. Their findings, which appear December ... Nature Nanotechnology , could dramatically simplify the way ... diseases. , The teamled by Mark ... Applied Science, and Tarek Fahmy, an associate professor ...
(Date:12/11/2009)... demand for premium fruit increases, growers are being ... And to boost their bottom line, orchard owners ... fruit quality while reducing labor costs. , Hand ... produce larger, healthier fruit, is among the most ... on fruit production overhead, and, ultimately, prices paid ...
(Date:12/11/2009)... identify and degrade the diverse types of defective proteins ... researchers Sabine C. Horn, Professor Thomas Sommer, Professor Udo ... Center for Molecular Medicine (MDC) Berlin-Buch, Germany, have now ... enzyme complex that plays a critical role in the ... the identification and disposal of various defectively produced proteins. ...
Breaking Biology News(10 mins):Scientists use nanosensors for first time to measure cancer biomarkers in blood 2Horizontal string trimmer reduces labor costs, increases peach size 2MDC researchers identify a scaffold regulating protein disposal 2Sangamo BioSciences Announces Presentation at the Needham Life Sciences Conference 12455 1Sangamo BioSciences Announces Presentation at the Needham Life Sciences Conference 12455 2IMAGINE Software Unveils Advanced IMAGINEradiology 28TM 29 Features 47841 1IMAGINE Software Unveils Advanced IMAGINEradiology 28TM 29 Features 47841 2Ambry Genetics Announces Launch of Chromosomal Microarray to Offer Whole Genome Analysis 47837 1Ambry Genetics Announces Launch of Chromosomal Microarray to Offer Whole Genome Analysis 47837 2Ambry Genetics Announces Launch of Chromosomal Microarray to Offer Whole Genome Analysis 47837 3
... Institute (NCI) and the National Human Genome Research ... of Health (NIH), today launched a comprehensive effort ... of cancer through the application of genome analysis ... called The Cancer Genome Atlas (TCGA), will begin ...
... the University of Pennsylvania School of Medicine have discovered ... RNA (pre-mRNA), a process once believed to only take ... this capability in dendrites, the investigators hope to relate ... cognitive dysfunction. Senior author James Eberwine, PhD, Professor of ...
... described as a mutation in mice that causes rapid ... humans from cancer. , Now, a team of ... has shown that the Quaking gene likely suppresses tumor ... GLI1, a cancer-causing oncogene highly associated with severe birth ...
Other Biology News:NIH launches comprehensive effort to explore cancer genomics 2NIH launches comprehensive effort to explore cancer genomics 3NIH launches comprehensive effort to explore cancer genomics 4RNA splicing occurs in nerve-cell dendrites 2RNA splicing occurs in nerve-cell dendrites 3Researchers discover new form of cancer gene regulation 2Researchers discover new form of cancer gene regulation 3
... DTNB , Ellman's reagent ... 69-78-3 *Storage: RT, When an enzyme-catalyzed ... not present in the substrate, it may be ... directly with the product to form a chromophore. ...
Borrelia Burgdorfen (IgG) -Ab EIA Sample Size: 100 l...
... is a protein based inhibitor of nonhuman ... most common and troublesome RNases including RNase ... can be used in any application where ... ideal for in vitro transcription and translation, ...
... RNaseOUT Recombinant Ribonuclease Inhibitor is ... pancreatic-type ribonucleases such as RNase ... RNaseOUT Recombinant Ribonuclease Inhibitor is ... molecular weight ~52 kDa. RNaseOUT ...
Biology Products: